Gerwin Heller
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
-
- Epigenetics and DNA Methylation 20
- RNA modifications and cancer 9
- Cancer-related gene regulation 9
- Oncology 32
- Cancer Immunotherapy and Biomarkers 13
- Co-authors
- Sabine Zöchbauer‐Müller (22 shared papers)Christoph Zielinski (16 shared papers)Barbara Ziegler (11 shared papers)Leonhard Müllauer (12 shared papers)Veronika Sexl (14 shared papers)Erwin Tomasich (21 shared papers)Adelheid End‐Pfützenreuter (7 shared papers)György Láng (7 shared papers)
- Journals
- Blood (7 papers)Clinical Cancer Research (3 papers)Cancers (3 papers)Oncotarget (3 papers)Cancer Research (3 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Gerwin Heller
74 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 485
- Hematology 266
- Oncology 583
- Molecular Biology 1.2k
- Immunology 333
Countries citing papers authored by Gerwin Heller
This map shows the geographic impact of Gerwin Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerwin Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerwin Heller more than expected).
Fields of papers citing papers by Gerwin Heller
This network shows the impact of papers produced by Gerwin Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerwin Heller. The network helps show where Gerwin Heller may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerwin Heller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 166 | |
| 2 | 2008 | 132 | |
| 3 | 2012 | 128 | |
| 4 | 2016 | 123 | |
| 5 | 2017 | 106 | |
| 6 | 2017 | 100 | |
| 7 | 2010 | 86 | |
| 8 | 2007 | 73 | |
| 9 | 2014 | 72 | |
| 10 | 2005 | 67 | |
| 11 | 2013 | 59 | |
| 12 | 2007 | 55 | |
| 13 | 2016 | 47 | |
| 14 | 2006 | 43 | |
| 15 | 2005 | 37 | |
| 16 | 2019 | 36 | |
| 17 | 2021 | 34 | |
| 18 | 2012 | 31 | |
| 19 | 2020 | 28 | |
| 20 | 2021 | 28 |
About Gerwin Heller
Gerwin Heller is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Cancer Research, having authored 77 papers that have together received 2.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (20 papers), Cancer Immunotherapy and Biomarkers (13 papers), Acute Myeloid Leukemia Research (12 papers), RNA modifications and cancer (9 papers), Cancer-related gene regulation (9 papers), Immune Cell Function and Interaction (8 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Cancer Research (485 citations), Hematology (266 citations), Oncology (583 citations), Molecular Biology (1.2k citations) and Immunology (333 citations). Gerwin Heller has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Sabine Zöchbauer‐Müller, Christoph Zielinski, Barbara Ziegler, Leonhard Müllauer, Veronika Sexl, Erwin Tomasich, Adelheid End‐Pfützenreuter, György Láng, Karoline Kollmann and Matthias Preusser. Their work appears in journals such as Blood, Clinical Cancer Research, Cancers, Oncotarget and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.